- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05044260
Sinus Lift Using PTFE Titanium Reinforced Membrane
September 6, 2021 updated by: Hams Hamed Abdelrahman
Evaluation of Direct Sinus Lift Using Ptfe Titanium Reinfored Membrane Assosiated With Immediate Implant Placement (Clinical Trial)
Various attempts have been implemented using different materials and techniques to augment the maxillary sinus floor enhancing autogenous bone formation to allow proper dental implant positioning.
The aim of this study is to evaluate the sinus lift procedure using polytetrafluoroethylene (PTFE) titanium-reinforced membrane to maintain the space formed after Schneiderian membrane elevation followed by immediate implant placement.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt
- Alexandria Faculty of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
36 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients of both genders requiring implant placement in posterior maxilla
- Age range: 40-60 years.
- Good oral hygiene
- Healthy maxillary sinus free from pathology
- The minimum crestal bone height is (4-6) mm
- Patients who are willing and fully capable to comply with the study protocol.
Exclusion Criteria:
- Sinus infection
- Tumors or pathologic lesions in sinus
- Severe allergic rhinitis.
- Chronic topical steroid use.
- Radiation therapy.
- Psychologic / mental impairment
- Acute infection (periodontitis or mucosal infection
- Patients on radiotherapy or chemotherapy.
- Alcohol or drug abuse.
- Patient with systemic disorder (uncontrolled Diabetes mellitus, autoimmune diseases, bone diseases, etc.)
- Smokers
- Parafuctional habits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Direct Sinus elevation using SLA Kit
|
Implants will be placed immediately after sinus lifting procedure and maintaining the sinus membrane in position using PTFE titanium reinforced membrane.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in implant stability
Time Frame: at baseline and 6 months
|
It will be measured using Osstell
|
at baseline and 6 months
|
|
Change in bone formation
Time Frame: at baseline and 6 months
|
It will be measured uisng CBCT on Demand 3d software
|
at baseline and 6 months
|
|
Change in bone height
Time Frame: at baseline and 6 months
|
It will be measured uisng CBCT on Demand 3d software
|
at baseline and 6 months
|
|
Change in bone density
Time Frame: at baseline and 6 months
|
It will be measured uisng CBCT on Demand 3d software
|
at baseline and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2020
Primary Completion (Anticipated)
October 20, 2021
Study Completion (Anticipated)
October 20, 2021
Study Registration Dates
First Submitted
September 6, 2021
First Submitted That Met QC Criteria
September 6, 2021
First Posted (Actual)
September 14, 2021
Study Record Updates
Last Update Posted (Actual)
September 14, 2021
Last Update Submitted That Met QC Criteria
September 6, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- sinus_lift2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sinus Lift
-
Mansoura UniversityCompleted
-
Cairo UniversityUnknown
-
Cairo UniversityUnknownMaxillary Sinus Lift
-
Studio Odontoiatrico Associato Dr. P. Cicchese...Not yet recruitingSinus Lift Augmentation
-
University of BaghdadRecruitingMaxillary Sinus Elevation | Sinus Lift Surgery ComplicationsIraq
-
Hams Hamed AbdelrahmanNot yet recruitingMaxillary Sinus Lift | OsteotomeLebanon
-
Mansoura UniversityNot yet recruitingSinus Lift AugmentationEgypt
-
Hams Hamed AbdelrahmanUnknown
Clinical Trials on Direct sinus lift with titanium reinforced PTFE membrane
-
Universidade do PortoCompletedAlveolar Bone Loss | Alveolar Ridge Deficiency | Jaw AtrophyPortugal
-
University GhentRecruitingAlveolar Ridge EnlargementBelgium
-
Mansoura UniversityCompleted
-
Mansoura UniversityNot yet recruitingSinus Lift AugmentationEgypt